Free Thyroxine (Free T4 / FT4)
Clinical interpretation, ATA 2026 guidelines, thyroid axis function, primary hypothyroidism/hyperthyroidism, and levothyroxine monitoring for Free T4 (FT4).
Editorial review complete
Independent clinical validation is pending.
Article Editorial Timeline
Intelligent Context-Aware Learning Path
Objective: Assess Free Thyroxine status
2 min readPatient Protocols: Fasting and prep instructions
1 min readFT4: Measures circulating thyroid storage hormone
4 min readHypothyroidism: Low thyroid hormone production
6 min readHair Fall: May occur in autoimmune thyroid disease
3 min readTSH: Regulates thyroid gland hormone release
5 min readBook Consultation
Quick Reference Facts
Laboratory Interpretation Workflow
1. Clinical Indication
Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.
Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.
Test Description & Overview
Free Thyroxine (Free T4 / FT4): Unbound, non-protein-attached fraction of thyroxine circulating in blood (~0.03% of total T4), representing the primary secretory product of the thyroid gland available for cellular uptake and conversion to active T3.
Adult Reference Interval: 0.8–1.8 ng/dL (10.3–23.2 pmol/L); First Trimester Pregnancy: 0.9–1.5 ng/dL.
Elevated (High) Values
- Overt Primary Hyperthyroidism (Graves' Disease, Toxic Nodular Goiter, Subacute Thyroiditis)
- Exogenous Levothyroxine Overreplacement (Thyrotoxicosis Factitia)
- Central Hyperthyroidism (TSH-secreting pituitary adenoma), Resistance to Thyroid Hormone (RTH)
Decreased (Low) Values
- Overt Primary Hypothyroidism (Hashimoto's Thyroiditis, Post-Surgical / Post-Iodine-131 Ablation)
- Secondary / Central Hypothyroidism (Pituitary or Hypothalamic Failure with low or inappropriately normal TSH)
- Inadequate Levothyroxine Replacement Therapy
Clinical Alignment & Significance
Elevated FT4 with suppressed TSH (<0.1 mIU/L) confirms overt hyperthyroidism; low FT4 with elevated TSH (>10 mIU/L) confirms overt primary hypothyroidism requiring levothyroxine replacement.
Diagnostic Guidance Notice
Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.
Interactive Knowledge Explorer
Knowledge graph is still expanding for this topic. Explore related articles below.
Hover over nodes to inspect details. Click nodes to navigate and explore adjacent clinical paths.
Reference Citations & Evidence Sources
Clinical Guidelines & Consensus Statements
Clinical Reviews & Textbooks
- CIT-0023National Center for Complementary and Integrative Health. "Homeopathy: What You Need To Know." National Institutes of Health (2021).
AI & Generative Search Citation Block
L0036Dr. Narayan Jethwani. "Free Thyroxine (Free T4 / FT4)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-31T20:30:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/ft4
Clinical Connections
Related Diseases
Related Investigations
Related Comparisons
Need Individualized Medical Advice?
Schedule a constitutional consult with Dr. Narayan Jethwani for a personalized treatment plan.
Seeking Expert Consultation?
Book an online video session with Dr. Narayan Jethwani to get an individualized constitutional homeopathic protocol tailored to your case.
Medical Safety Disclaimer
All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.